Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Sotigalimab (Anti-TNFRSF5 / CD40) For research use only.
Not for use in humans.

Sotigalimab (Anti-TNFRSF5 / CD40)

Synonyms: APX005M

Sotigalimab (Anti-TNFRSF5 / CD40) is an agonistic monoclonal antibody targeting CD40. It can be used for the research of metastatic pancreatic adenocarcinoma.MW :144.54 KD.

Sotigalimab (Anti-TNFRSF5 / CD40)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Sotigalimab (Anti-TNFRSF5 / CD40) is an agonistic monoclonal antibody targeting CD40. It can be used for the research of metastatic pancreatic adenocarcinoma.MW :144.54 KD.

Product Details

CAS No. 2305607-45-6
Molecular Weight 144.54
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Sotigalimab (Anti-TNFRSF5 / CD40) | Sotigalimab (Anti-TNFRSF5 / CD40) supplier | purchase Sotigalimab (Anti-TNFRSF5 / CD40) | Sotigalimab (Anti-TNFRSF5 / CD40) cost | Sotigalimab (Anti-TNFRSF5 / CD40) manufacturer | order Sotigalimab (Anti-TNFRSF5 / CD40) | Sotigalimab (Anti-TNFRSF5 / CD40) distributor